9th Mar 2005 17:32
Allergy Therapeutics PLC09 March 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company ALLERGY THERAPEUTICS PLC 2. Name of director CHRISTIAN GRATZ 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) N/A 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary N/A 7. Number of shares / amount of stock acquired N/A 8. Percentage of issued class N/A 9. Number of shares/amount of stock disposed N/A 10. Percentage of issued class N/A 11. Class of security N/A 12. Price per share N/A 13. Date of transaction N/A 14. Date company informed N/A 15. Total holding following this notification N/A 16. Total percentage holding of issued class following this notification N/A If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 8TH MARCH 2005 18. Period during which or date on which exercisable 8TH MARCH 2008 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved: class, number 200,000 OPTIONS OF 0.1p ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise £1.004 22. Total number of shares or debentures over which options held following thisnotification TOTAL ORDINARY SHARE OPTIONS HELD = 2,356,000 23. Any additional information ............................................................... 24. Name of contact and telephone number for queries 01903 844709 FRANCESCA WEST 25. Name and signature of authorised company official responsible for makingthis notification Andrew Turnbull............................................................... Date of Notification 9TH MARCH 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company ALLERGY THERAPEUTICS PLC 2. Name of director ANDREW TURNBULL 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) N/A 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary N/A 7. Number of shares / amount of stock acquired N/A 8. Percentage of issued class N/A 9. Number of shares/amount of stock disposed N/A 10. Percentage of issued class N/A 11. Class of security N/A 12. Price per share N/A 13. Date of transaction N/A 14. Date company informed N/A 15. Total holding following this notification N/A 16. Total percentage holding of issued class following this notification N/A If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 8TH MARCH 2005 18. Period during which or date on which exercisable 8TH MARCH 2008 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved: class, number 300,000 OPTIONS OF 0.1p ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise £1.004 22. Total number of shares or debentures over which options held following thisnotification TOTAL ORDINARY SHARE OPTIONS HELD = 3,507,100 23. Any additional information ............................................................... 24. Name of contact and telephone number for queries 01903 844709 FRANCESCA WEST 25. Name and signature of authorised company official responsible for makingthis notification Andrew Turnbull............................................................... Date of Notification 9TH MARCH 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company ALLERGY THERAPEUTICS PLC 2. Name of director TOM HOLDICH 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) N/A 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary N/A 7. Number of shares / amount of stock acquired N/A 8. Percentage of issued class N/A 9. Number of shares/amount of stock disposed N/A 10. Percentage of issued class N/A 11. Class of security N/A 12. Price per share N/A 13. Date of transaction N/A 14. Date company informed N/A 15. Total holding following this notification N/A 16. Total percentage holding of issued class following this notification N/A If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 8TH MARCH 2005 18. Period during which or date on which exercisable 8TH MARCH 2008 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved: class, number 200,000 OPTIONS OF 0.1p ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise £1.004 22. Total number of shares or debentures over which options held following thisnotification TOTAL ORDINARY SHARE OPTIONS HELD = 430,000 23. Any additional information ............................................................... 24. Name of contact and telephone number for queries 01903 844709 FRANCESCA WEST 25. Name and signature of authorised company official responsible for makingthis notification Andrew Turnbull............................................................... Date of Notification 9TH MARCH 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company ALLERGY THERAPEUTICS PLC 2. Name of director IAN POSTLETHWAITE 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) N/A 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary N/A 7. Number of shares / amount of stock acquired N/A 8. Percentage of issued class N/A 9. Number of shares/amount of stock disposed N/A 10. Percentage of issued class N/A 11. Class of security N/A 12. Price per share N/A 13. Date of transaction N/A 14. Date company informed N/A 15. Total holding following this notification N/A 16. Total percentage holding of issued class following this notification N/A If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 8TH MARCH 2005 18. Period during which or date on which exercisable 8TH MARCH 2008 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved: class, number 300,000 OPTIONS OF 0.1p ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise £1.004 22. Total number of shares or debentures over which options held following thisnotification TOTAL ORDINARY SHARE OPTIONS HELD = 3,650,000 23. Any additional information ............................................................... 24. Name of contact and telephone number for queries 01903 844709 FRANCESCA WEST 25. Name and signature of authorised company official responsible for makingthis notification Andrew Turnbull ............................................................ Date of Notification 9TH MARCH 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company ALLERGY THERAPEUTICS PLC 2. Name of director KEITH CARTER 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) N/A 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary N/A 7. Number of shares / amount of stock acquired N/A 8. Percentage of issued class N/A 9. Number of shares/amount of stock disposed N/A 10. Percentage of issued class N/A 11. Class of security N/A 12. Price per share N/A 13. Date of transaction N/A 14. Date company informed N/A 15. Total holding following this notification N/A 16. Total percentage holding of issued class following this notification N/A If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 8TH MARCH 2005 18. Period during which or date on which exercisable 8TH MARCH 2008 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved: class, number 600,000 OPTIONS OF 0.1p ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise £1.004 22. Total number of shares or debentures over which options held following thisnotification TOTAL ORDNIARY SHARE OPTIONS HELD = 2,150,000 23. Any additional information ............................................................... 24. Name of contact and telephone number for queries 01903 844709 FRANCESCA WEST 25. Name and signature of authorised company official responsible for makingthis notification Andrew Turnbull............................................................... Date of Notification 9TH MARCH 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.